{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:28:12Z","timestamp":1759073292824,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,3]],"date-time":"2011-07-03T00:00:00Z","timestamp":1309651200000},"content-version":"vor","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.cbi.2010.06.011","type":"journal-article","created":{"date-parts":[[2010,7,4]],"date-time":"2010-07-04T04:12:29Z","timestamp":1278216749000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic treatment with cyclosporine affects systemic purinergic parameters, homocysteine levels and vascular disturbances in rats"],"prefix":"10.1016","volume":"188","author":[{"given":"Ana Elisa","family":"B\u00f6hmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz Marina P.","family":"Brum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Guerini","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Mendes Ribeiro","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Pierre","family":"Oses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giordano Gubert","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Jaconi","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Driemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Valmor","family":"Portela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo Onofre","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cbi.2010.06.011_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.transproceed.2009.05.001","article-title":"Forty years of publication of transplantation proceedings\u2014the second decade: the cyclosporine revolution","volume":"41","author":"Kahan","year":"2009","journal-title":"Transplant Proc."},{"issue":"1 Suppl.","key":"10.1016\/j.cbi.2010.06.011_bib2","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.tp.0000231505.91988.26","article-title":"Drugs modulating endothelial function after transplantation","volume":"82","author":"Nickel","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/FTD.0b013e31816b9063","article-title":"Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges","volume":"30","author":"Christians","year":"2008","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.cbi.2010.06.011_bib4","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.CIR.96.6.2069","article-title":"Cardiac allograft vasculopathy: a review","volume":"96","author":"Weis","year":"1997","journal-title":"Circulation"},{"issue":"6 Suppl. 6","key":"10.1016\/j.cbi.2010.06.011_bib5","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1053\/ajkd.2001.28924","article-title":"Cardiovascular disease and the renal transplant recipient","volume":"38","author":"Kendrick","year":"2001","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/mi.4.2.7","article-title":"Biochemical mechanisms of cyclosporine neurotoxicity","volume":"4","author":"Serkova","year":"2004","journal-title":"Mol. Interv."},{"issue":"5","key":"10.1016\/j.cbi.2010.06.011_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.108.182865","article-title":"Chemokines and transplant vasculopathy","volume":"103","author":"Belperio","year":"2008","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2003.08.002","article-title":"Immunosuppression and transplant vascular disease: benefits and adverse effects","volume":"100","author":"Moien-Afshari","year":"2003","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cbi.2010.06.011_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007890-199602150-00034","article-title":"Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients","volume":"61","author":"Arnadottir","year":"1996","journal-title":"Transplantation"},{"issue":"4 Suppl.","key":"10.1016\/j.cbi.2010.06.011_bib10","doi-asserted-by":"crossref","first-page":"1238S","DOI":"10.1093\/jn\/126.suppl_4.1238S","article-title":"Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases","volume":"126","author":"Malinow","year":"1996","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.cbi.2010.06.011_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/ehn515","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.cbi.2010.06.011_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0735-1097(95)00508-0","article-title":"Homocysteine and coronary atherosclerosis","volume":"27","author":"Mayer","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2010.06.011_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2261-8-24","article-title":"The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis","volume":"8","author":"Potter","year":"2008","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cbi.2010.06.011_bib14","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"1279","article-title":"Disorders of transulfuration","author":"Mudd","year":"2001"},{"issue":"1","key":"10.1016\/j.cbi.2010.06.011_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI118776","article-title":"The oxidant stress of hyperhomocyst(e)inemia","volume":"98","author":"Loscalzo","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"2\u20133","key":"10.1016\/j.cbi.2010.06.011_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2008.01.053","article-title":"Human in vivo research on the vascular effects of adenosine","volume":"585","author":"Riksen","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2010.06.011_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dnp.2003.16.3.876886","article-title":"Involvement of purinergic signaling in cardiovascular diseases","volume":"16","author":"Ralevic","year":"2003","journal-title":"Drug News Perspect."},{"issue":"6","key":"10.1016\/j.cbi.2010.06.011_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/PL00004904","article-title":"Inhibition of platelet aggregation by adenosine receptor agonists","volume":"349","author":"Cristalli","year":"1994","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.cbi.2010.06.011_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cbi.2010.06.011_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.65.3.531","article-title":"Metabolism of adenine nucleotides in human blood","volume":"65","author":"Coade","year":"1989","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2005-869527","article-title":"Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation","volume":"31","author":"Robson","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.cbi.2010.06.011_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1242\/dev.02233","article-title":"Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation","volume":"133","author":"Mishra","year":"2006","journal-title":"Development"},{"issue":"26","key":"10.1016\/j.cbi.2010.06.011_bib23","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/j.lfs.2003.11.020","article-title":"Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum","volume":"74","author":"Oses","year":"2004","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","article-title":"A direct colorimetric assay for Ca2+-stimulated ATPase activity","volume":"157","author":"Chan","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2010.06.011_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.cbi.2010.06.011_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.2008.00025.x","article-title":"Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors","volume":"156","author":"Schmidt","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2010.06.011_bib27","article-title":"Long-term cyclosporine treatment: evaluation of serum biochemical parameters and histopathological alterations in Wistar rats","author":"Elisa Bohmer","year":"2009","journal-title":"Exp. Toxicol. Pathol."},{"issue":"13","key":"10.1016\/j.cbi.2010.06.011_bib28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cbi.2010.06.011_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0009-9120(96)00172-5","article-title":"Clinical chemistry and molecular biology of homocysteine metabolism: an update","volume":"30","author":"Miner","year":"1997","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.cbi.2010.06.011_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/cs0610743","article-title":"Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism","volume":"61","author":"Wilcken","year":"1981","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4065\/70.2.125","article-title":"Increase in total plasma homocysteine concentration after cardiac transplantation","volume":"70","author":"Berger","year":"1995","journal-title":"Mayo Clin. Proc."},{"issue":"10","key":"10.1016\/j.cbi.2010.06.011_bib32","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/01.ATV.17.10.1894","article-title":"Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients","volume":"17","author":"Bostom","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.cbi.2010.06.011_bib33","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/clinchem\/44.11.2307","article-title":"Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients","volume":"44","author":"Cole","year":"1998","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.cbi.2010.06.011_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00392-004-0075-3","article-title":"Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases","volume":"93","author":"Stanger","year":"2004","journal-title":"Z. Kardiol."},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2006.01.004","article-title":"In vitro effect of homocysteine on nucleotide hydrolysis by blood serum from adult rats","volume":"160","author":"Bohmer","year":"2006","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cbi.2010.06.011_bib36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1515\/CCLM.2005.175","article-title":"Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia","volume":"43","author":"Riksen","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cbi.2010.06.011_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.ATV.0000150651.85907.69","article-title":"Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia","volume":"25","author":"Riksen","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.cbi.2010.06.011_bib38","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/01.CIR.0000027586.64231.1B","article-title":"Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"issue":"4\u20135","key":"10.1016\/j.cbi.2010.06.011_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002100000318","article-title":"Metabolic flux rates of adenosine in the heart","volume":"362","author":"Deussen","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2010.06.011_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0008-6363(03)00462-0","article-title":"Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia","volume":"59","author":"Riksen","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.cbi.2010.06.011_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2010.02.029","article-title":"Long-term cyclosporine treatment in non transplanted rats and metabolic risk factors of vascular diseases","volume":"185","author":"B\u00f6hmer","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"11","key":"10.1016\/j.cbi.2010.06.011_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF03402098","article-title":"Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection","volume":"5","author":"Imai","year":"1999","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.cbi.2010.06.011_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1389450023347713","article-title":"Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition","volume":"3","author":"Gendron","year":"2002","journal-title":"Curr. Drug Targets"},{"issue":"5","key":"10.1016\/j.cbi.2010.06.011_bib44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710003935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710003935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:22:41Z","timestamp":1757856161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279710003935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0009279710003935"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2010.06.011","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic treatment with cyclosporine affects systemic purinergic parameters, homocysteine levels and vascular disturbances in rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2010.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}